Zoekresultaten - 1 result
Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020).
(TAT) was 24 hours (IQR 2-48 hours). Invalid sample rate was 2.0% (9¼500). Concordance between the Cepheid and COBAS was 86.2% (kappa value = 0.71). Of 1042 healthcare workers, only 5.6% (58/1042) were ...